Gene expression profiling in acute myeloid leukemia

Haematologica

Volumn 91, Issue 6, 2006, Pages 733-738

  Bullinger, Lars ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANILINE DERIVATIVE; FLT3 LIGAND; GEFITINIB; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; CHROMOSOME ABERRATION; CYTOGENETICS; DISEASE CLASSIFICATION; DRUG INHIBITION; EDITORIAL; GENE EXPRESSION PROFILING; GENE MUTATION; GENOME; HUMAN; KARYOTYPE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR GENETICS; PROGNOSIS; WORLD HEALTH ORGANIZATION;

ACUTE DISEASE; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID; PROGNOSIS; TREATMENT OUTCOME;

EID: 33745748302     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (40)

1. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292-302.
2. Schlenk RF, Benner A, Krauter J, Buchner T, Sauerland C, Ehninger G, et al. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol 2004;22:3741-50.
3. Frohling S, Scholl C, Gilliland DG, Levine RL. Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 2005;23:6285-95.
4. Licht JD, Sternberg DW. The molecular pathology of acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 2005:137-42.
5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7.
6. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 2001;98:1124-9.
7. Rucker FG, Bullinger L, Kestler HA, Lichter P, Dohner K, Dohner H. Parallel analyses disclose novel genomic imbalances in acute myeloid leukemia with complex karyotypes. Blood (ASH Annual Meeting Abstracts) 2005;106:2357.
8. Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann W, Schnittger S, et al. Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia 2005;19:1224-8.
9. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004;350:1605-16.
10. Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, Rohatiner A, et al. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer 2003;37:149-58.
11. Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, et al. Molecular characterization of acute leukemias by use of microarray technology. Genes Chromosomes Cancer 2003;37:396-405.
12. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004;104:3679-87.
13. Schoch C, Kohlmann A, Schnittger S, Brors B, Dugas M, Mergenthaler S, et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci USA 2002;99:10008-13.
14. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004;350:1617-28.
15. Lacayo NJ, Meshinchi S, Kinnunen P, Yu R, Wang Y, Stuber CM, et al. Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. Blood 2004;104:2646-54.
16. Neben K, Schnittger S, Brors B, Tews B, Kokocinski F, Haferlach T, et al. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype. Oncogene 2005;24:1580-8.
17. Vey N, Mozziconacci MJ, Groulet-Martinec A, Debono S, Finetti P, Carbuccia N, et al. Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling. Oncogene 2004;23:9381-91.
18. Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP, et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005;106:899-902.
19. Verhaak RG, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W, et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 2005;106:3747-54.
20. Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W, et al. Global approach to the diagnosis of leukemia using gene expression profiling. Blood 2005;106:1189-98.
21. Kohlmann A, Schoch C, Dugas M, Rauhut S, Weninger F, Schnittger S, et al. Pattern robustness of diagnostic gene expression signatures in leukemia. Genes Chromosomes Cancer 2005;42:299-307.
22. Kern W, Kohlmann A, Schnittger S, Schoch C, Haferlach T. Role of gene expression profiling for diagnosing acute leukemias. Rev Clin Exp Hematol 2005;9:E1.
23. Bullinger L, Kurz S, Dohner K, Scholl C, Frohling S, Schlenk RF, et al. Gene expression profiling identifies distinct subclasses in core binding factor acute myeloid leukemia. Blood (ASH Annual Meeting Abstracts) 2005;106:673.
24. Park DJ, Vuong PT, de Vos S, Douer D, Koeffler HP. Comparative analysis of genes regulated by PML/RARα and PLZF/RARα in response to retinoic acid using oligonucleotide arrays. Blood 2003;102:3727-36.
25. Witcher M, Ross DT, Rousseau C, Deluca L, Miller WH Jr. Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells. Blood 2003;102:237-45.
26. Meani N, Minardi S, Licciulli S, Gelmetti V, Coco FL, Nervi C, et al. Molecular signature of retinoic acid treatment in acute promyelocytic leukemia. Oncogene 2005;24:3358-68.
27. Stegmaier K, Ross KN, Colavito SA, O'Malley S, Stockwell BR, Golub TR. Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation. Nat Genet 2004;36:257-63.
28. Stegmaier K, Corsello SM, Ross KN, Wong JS, Deangelo DJ, Golub TR. Gefitinib induces myeloid differentiation of acute myeloid leukemia. Blood 2005;106:2841-8.
29. Dorsam ST, Ferrell CM, Dorsam GP, Derynck MK, Vijapurkar U, Khodabakhsh D, et al. The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood 2004;103:1676-84.
30. Dohner K, Schlenk RF, Habdank M, Scholl C, Rucker FG, Corbacioglu A, et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 2005;106:3740-6.
31. Heuser M, Wingen LU, Steinemann D, Cario G, von Neuhoff N, Tauscher M, et al. Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia. Haematologica 2005;90:1484-92.
32. Yagi T, Morimoto A, Eguchi M, Hibi S, Sako M, Ishii E, et al. Identification of a gene expression signature associated with pediatric AML prognosis. Blood 2003;102:1849-56.
33. Bair E, Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2004;2:E108.
34. Marcucci G, Radmacher MD, Ruppert AS, Mrozek K, Kolitz JE, Whitman SP, et al. Independent validation of prognostic relevance of a previously reported gene-expression signature in acute myeloid leukemia (AML) with normal cytogenetics (NC): a Cancer and Leukemia Group B (CALGB) Study. Blood ASH Annual Meeting Abstracts 2005;106:755 [abstract].
35. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005;115:1503-21.
36. Ebert BL, Golub TR. Genomic approaches to hematologic malignancies. Blood 2004;104:923-32.
37. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003;348:1777-85.
38. Bullinger L, Valk PJ. Gene expression profiling in acute myeloid leukemia. J Clin Oncol 2005;23:6296-305.
39. Nilsson B, Andersson A, Johansson M, Fioretos T. Cross-platform classification simplifies microarray-based leukemia diagnostics. Haematologica 2006;91:821-4.
40. Rucker FG, Sander S, Dohner K, Dohner H, Pollack JR, Bullinger L. Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations. Leukemia 2006;in press.